Učitavanje...
Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
In oncology, an increasing number of targeted anticancer agents and immunotherapies are of biological origin. These biological drugs may trigger immune responses that lead to the formation of antidrug antibodies (ADAs). ADAs are directed against immunogenic parts of the drug and may affect efficacy...
Spremljeno u:
| Izdano u: | Oncologist |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061540/ https://ncbi.nlm.nih.gov/pubmed/27440064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0061 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|